Skip to content
Lawsuit Help Desk

Lawsuit News Center

Shocking Vision Loss: What Beovu Users Aren't Being Told About This Controversial Drug

Shocking Vision Loss: What Beovu Users Aren’t Being Told About This Controversial Drug

Beovu: A Miraculous Drug or A Nightmare in Disguise?

Approved by the FDA, Beovu (brolucizumab) was hailed as a promising treatment for wet age-related macular degeneration (AMD), a leading cause of vision loss among the elderly. Its prowess lay in its ability to reduce the frequency of eye injections needed by these patients. But has the veil of this breakthrough lifted to reveal a darker reality?

The controversy began when reports of 14 cases of vasculitis in patients that had taken Beovu surfaced. Vasculitis is an inflammation of the vascular branches of arteries in the retina, a condition that can impact vision severely. The majority of these cases (11 out of 14) developed into occlusive retinal vasculitis, a more severe form of vasculitis that could lead to blindness. If Novartis, the manufacturer of Beovu, had warned about these potential side effects, would patients have taken this treatment route?

Unveiling the Realities: The Unreported Side Effects of Beovu

Worsening the concern, Beovu's prescribing label initially omitted warnings about retinal vasculitis and occlusion, despite the common side effects listing blurred vision, cataracts, and eye hemorrhage. Not until February 2020 did the FDA approve a label change to include additional safety information about retinal vasculitis. By then, it seemed the bell could not be unrung.

One such case unfolded in August 2020, when a woman experienced acute visual acuity loss after taking Beovu and was later diagnosed with retinal vasculitis. Symptoms of this condition can vary from altered color vision, blurring of vision, to flashes, and even pain. Could this have been avoided had the prescribing label been more explicit?

Legal Crossfire: The Surge of Beovu Lawsuits Across the Nation

Disturbed by these revelations, several patients impacted have started to exert legal pressure on Novartis. Beovu lawsuits, claiming the drug's manufacturer failed to warn about potential vision side effects, have been filed in multiple courts across the country. However, as of July 6, 2023, no trials or court-approved settlements have been reached.

Interestingly, Novartis has attempted to dismiss some cases, but judges have allowed them to continue. Lawyers are still accepting cases, suggesting that the legal battle is far from over. The lawsuits are primarily filed against Novartis, the drug's manufacturer. But the question remains – were Novartis and the FDA aware of these potential side effects? Could they have done more to prevent or at least mitigate the damage caused?

Bitter Pills to Swallow: The Human Cost of Beovu's Controversies

Beyond the courtroom, the human cost of these alleged missteps paints a distressing picture. For those affected, vision loss is not just a medical condition. It's an alteration of their life's landscape, often leading to emotional distress, social isolation, and a drastic decrease in the quality of life. Not to mention the potential physical pain and discomfort these patients might have to endure.

Moreover, the emotional distress of legal battles can add more strain to their already suffering health. While compensation may provide some relief, it cannot restore their vision or erase the physical and emotional hardship they underwent. Is this the price patients have to pay for the alleged negligence of pharmaceutical giants?

Looking Ahead: Updates and Current Status of Beovu Litigations

As we navigate the complexities of these allegations and lawsuits, it's crucial to stay updated. Beovu lawsuits are still in the early stages. Despite the attempts by Novartis to dismiss these cases, judges have allowed them to continue, and lawyers continue to accept cases.

Conversely, Novartis stands by Beovu's safety and efficacy, labeling the reports as "rare post-marketing safety events." In addition, no recall for Beovu has been issued by Novartis or the FDA. The journey to justice seems long and arduous, but the victims of this alleged negligence are not backing down.

In the context of these allegations and the ongoing litigation, one can't help but wonder – could more have been done to prevent these unfortunate side effects? And as we look to the future, how can we ensure such incidents don't repeat themselves? The answers to these questions may hold the key to restoring the faith in our medical and legal institutions. has a mission to restore justice by finding every mass tort victim leading litigation counsel. Our services are free! We're also the leading information portal for people who have been injured from mass torts. We'd love to hear from you!